Search Results
(±)14(15)-DiHET-d11 50 µg | ≥99%
Cayman Chemical
(±)14(15)-DiHET-d11
(±)14(15)-DiHET-d11 25 µg | ≥99%
Cayman Chemical
(±)14(15)-DiHET-d11
(±)14(15)-DiHETE 100 µg | ≥98%
Cayman Chemical
(±)14(15)-DiHETE
(±)14(15)-DiHETE 50 µg | ≥98%
Cayman Chemical
(±)14(15)-DiHETE
(±)14(15)-DiHETE 25 µg | ≥98%
Cayman Chemical
(±)14(15)-DiHETE
(±)14(15)-EET 500 µg | ≥98%
Cayman Chemical
(±)14(15)-EET
(±)14(15)-EET 100 µg | ≥98%
Cayman Chemical
(±)14(15)-EET
(±)14(15)-EET 50 µg | ≥98%
Cayman Chemical
(±)14(15)-EET
(±)14(15)-EET 25 µg | ≥98%
Cayman Chemical
(±)14(15)-EET
(±)14(15)-EET 1 mg | Purity Not Available
TargetMol
(±)14(15)-EET is a metabolite of arachidonic acid that is formed via epoxidation of arachidonic acid by cytochrome P450.[1],[2] It prevents increases in leukotriene B4, ICAM-1, and chemokine (C-C motif) ligand 1 (CCL2) induced by oxidized LDL in primary rat pulmonary artery endothelial cells (RPAECs) when used at a concentration of 1 μM.[3] (±)14(15)-EET induces dilation […]
More Information Supplier Page